Literature DB >> 2985653

Isolation and partial characterization of a human alveolar macrophage-derived neutrophil-activating factor.

J E Pennington, T H Rossing, L W Boerth, T H Lee.   

Abstract

Human alveolar macrophages (AM) were obtained from eight normal volunteers using fiberoptic bronchoscopic lavage to explore potential interrelationships among leukocytes in pulmonary defense against infection. AM placed in monolayer tissue cultures released material into culture supernatants with the capacity to enhance the bactericidal capacity of human neutrophils. Neutrophils preexposed to supernatants killed Pseudomonas aeruginosa from 70 to 90% more efficiently than control cells (P less than 0.02). AM culture supernatants contained this material by 4 h of incubation, and in vitro stimulation of AM cultures with heat-killed P. aeruginosa further increased its production. Gel filtration of AM culture supernatants with a G-50 Sephadex column allowed isolation of a 6,000-D neutrophil-activating factor (NAF) that was resistant to heat (56 degrees C, 30 min). The isoelectric point of NAF, as determined by chromatofocusing, was approximately 7.6. Enzyme digestion of NAF specimens, prepared sequentially by gel filtration and chromatofocusing, demonstrated 50-70% loss of activity after incubations with trypsin, chymotrypsin, and neuraminidase. NAF was only minimally chemotactic and eluted from Sephadex G-50 with particles of a different molecular size than those of AM-derived chemotactic factors (i.e., approximately 10,000 D and less than 500 D). Preincubation of neutrophils with NAF resulted in greater release of superoxide anion upon their subsequent stimulation by either bacterial phagocytosis or by phorbol myristate acetate, as compared with control neutrophils stimulated in a like manner. These studies indicate that human AM secrete a heat-stable, low molecular weight basic protein, with the capacity to enhance oxidative microbicidal activity of neutrophils.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2985653      PMCID: PMC425449          DOI: 10.1172/JCI111820

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Quantitative aspects of the production of superoxide radicals by phagocytizing human granulocytes.

Authors:  R S Weening; R Wever; D Roos
Journal:  J Lab Clin Med       Date:  1975-02

2.  Generation of superoxide radicals by human peripheral neutrophils activated by chemotactic factor. Evidence for the role of calcium.

Authors:  L Simchowitz; I Spilberg
Journal:  J Lab Clin Med       Date:  1979-04

3.  Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent.

Authors:  B M Babior; R S Kipnes; J T Curnutte
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

Review 4.  Expression of immune mechanisms in the lung.

Authors:  H B Kaltreider
Journal:  Am Rev Respir Dis       Date:  1976-03

5.  Granulocyte transfusion therapy of experimental Pseudomonas pneumonia.

Authors:  D C Dale; H Y Reynolds; J E Pennington; R J Elin; T W Pitts; R G Graw
Journal:  J Clin Invest       Date:  1974-09       Impact factor: 14.808

6.  Stimulation of neutrophil oxygen-dependent metabolism by human leukocytic pyrogen.

Authors:  M S Klempner; C A Dinarello; W R Henderson; J I Gallin
Journal:  J Clin Invest       Date:  1979-10       Impact factor: 14.808

7.  Pathogenesis of Pseudomonas aeruginosa pneumonia during immunosuppression.

Authors:  J E Pennington; M G Ehrie
Journal:  J Infect Dis       Date:  1978-06       Impact factor: 5.226

8.  Enhancement of human neutrophil bactericidal activity by chemotactic factors.

Authors:  A C Issekutz; K Y Lee; W D Biggar
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

9.  Pulmonary alveolar macrophage. Defender against bacterial infection of the lung.

Authors:  E Goldstein; W Lippert; D Warshauer
Journal:  J Clin Invest       Date:  1974-09       Impact factor: 14.808

10.  Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor.

Authors:  S H Zigmond; J G Hirsch
Journal:  J Exp Med       Date:  1973-02-01       Impact factor: 14.307

View more
  10 in total

1.  Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage.

Authors:  T R Martin; G Raugi; T L Merritt; W R Henderson
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

2.  T cell-dependent chronic neutrophilia during mycobacterial infections.

Authors:  R Appelberg; M T Silva
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

Review 3.  Secretory products of macrophages.

Authors:  C F Nathan
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

4.  Enhancement of leukotriene C4 release from primate airway macrophages by cellular interactions.

Authors:  A M Campbell; S T Harper; C Hallam; E Wells; J Mann; C Robinson
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

5.  Cellular defense of the avian respiratory system: influx and nonopsonic phagocytosis by respiratory phagocytes activated by Pasteurella multocida.

Authors:  T E Toth; R H Pyle; T Caceci; P B Siegel; D Ochs
Journal:  Infect Immun       Date:  1988-05       Impact factor: 3.441

6.  Macrophage-produced oxygen radical generating activities for polymorphonuclear leukocytes.

Authors:  Y Tsukamoto; S Fukutani; M Nakatani; M Mori
Journal:  Inflammation       Date:  1989-06       Impact factor: 4.092

7.  Effect of recombinant human interleukin-2 on the course of experimental chronic respiratory tract infection caused by Klebsiella pneumoniae in mice.

Authors:  Y Iizawa; T Nishi; M Kondo; K Tsuchiya; A Imada
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

8.  Interferon-gamma activates human neutrophil oxygen metabolism and exocytosis.

Authors:  M A Cassatella; R Cappelli; V Della Bianca; M Grzeskowiak; S Dusi; G Berton
Journal:  Immunology       Date:  1988-03       Impact factor: 7.397

Review 9.  Cellular events in alveolitis and the evolution of pulmonary fibrosis.

Authors:  A Burkhardt; H Cottier
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1989

10.  A novel neutrophil-activating factor produced by human mononuclear phagocytes.

Authors:  P Peveri; A Walz; B Dewald; M Baggiolini
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.